AbbVie Qulipta Shows Benefit In Severely Afflicted Chronic Migraine Patients

 
• By Alaric DeArment
  
Migraine word written on wood block
AbbVie announced positive Phase III data for Qulipta in chronic migraine • Source: Shutterstock

More from Clinical Trials

More from R&D